Form D · Other Technology

Epoch Biotech, LLC

Dover, MA · CIK 0001984545

Offering snapshot reported Jan 14, 2026 · SEC filing

Reported sold
$300K
Offering amount: $1.7M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 22, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$150K$300KJun 26, 2025: $140,000.00Jun 26, 2025Nov 3, 2025: $240,000.00Nov 3, 2025Jan 14, 2026: $300,000.00Jan 14, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$140,000 → $300,000
  • Reported investors3 → 5

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 14, 2026Amendment$300,000$160,000vs Jun 26, 20255SEC filing
Nov 3, 2025Amendment$240,000$100,000vs Jun 26, 20254SEC filing
Jun 26, 2025Initial$140,000No comparison3SEC filing
Jul 18, 2024Initial$40,000No comparison2SEC filing
Jul 12, 2023Initial$720,000No comparison10SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-550019

Source: Form D, filed Jan 14, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael R. Aceti Director, Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
3 Crest Drive
Dover, MA, 02030